June 13, 2020

We are not out of the woods yet, but it is safe to say that many B2B buyers are re-emerging to do business.

Free Book Preview No BS Guide to Direct Response Social Media Marketing

The ultimate guide to – producing measurable, monetizable results with social media marketing.

5 min read

Opinions expressed by Entrepreneur contributors are their own.

The pandemic is far from over, and there is still a massive amount of economic pain and high unemployment, but in the world of B2B , we seem to be emerging from the other side of the crisis and entering a kind of New Normal. Some businesses are reopening, some are testing the waters again after being hesitant to spend or invest during the lowest points of the crisis, and the stock market has recovered much of its losses. Although we are not completely out of

The banking and financial sector is among the worst hit in the current downturn. While the Nifty 50 has declined 27.1 per cent over the past three months, the Nifty Bank index has nosedived 39.4 per cent over the same period. The steep correction, however, presents longer-term investors with good entry points into quality stocks within this sector.

This sector’s prospects are bound closely to that of the economy. And with economic growth poised to slow down considerably—the International Monetary Fund has projected a GDP growth rate of 1.9 per cent in FY21—the banking and financial sector will bear the brunt. There are fears of a spike in bad “The market fears that the slowdown could lead to potential job losses. That could in turn cause stress in the retail loan books of banks. Similarly, loss of production could lead to stress emerging in corporate,

The insurance regulator, Insurance Regulatory and Development Authority (IRDAI), has revised the guidelines for a standard covid product from the earlier draft guidelines issued by it. In a fresh draft, the regulator asked general insurance companies and standalone health to offer a “standard benefit based product” rather than an indemnity based health product which was proposed earlier.

The standard benefit based product will offer a lump sum benefit equal to 100 per cent of the sum insured which will be paid by the if an insured tests positive novel (Covid-19), resulting in hospitalisation. “The diagnosis has to be confirmed by authorized centers as declared by the Ministry of Health and Family Welfare, Government of India”, said the draft guidelines reviewed by Business Standard.

The minimum sum assured for the product will be Rs 50,000 and it can go upto a

Market regulator on Friday modified its framework for (AMCs) making investment from the funds raised through a new fund offer.

The move is aimed at ensuring money remains within the scheme, which will provide some cushion to mutual fund unitholders in case of winding up of a scheme, industry experts said.

Under the mutual fund norms, the sponsor or AMC is required to invest at least one per cent of the amount which would be raised in the new fund offer (NFO) or Rs 50 lakh, whichever is less in such option of the scheme.

Now, the regulator has decided that this investment will be made in growth option of the scheme. It further said for such schemes where growth option is not available, the investment will be made in the dividend reinvestment option of